Cargando…
Primidone blocks RIPK1-driven cell death and inflammation
The receptor-interacting serine/threonine protein kinase 1 (RIPK1) is a key mediator of regulated cell death and inflammation. Recent studies suggest that RIPK1 inhibition would fundamentally improve the therapy of RIPK1-dependent organ damage in stroke, myocardial infarction, kidney failure, and sy...
Autores principales: | Riebeling, Theresa, Jamal, Kunzah, Wilson, Rebecca, Kolbrink, Benedikt, von Samson-Himmelstjerna, Friedrich Alexander, Moerke, Caroline, Ramos Garcia, Laura, Dahlke, Eileen, Michels, Friederike, Lühder, Fred, Schunk, Domagoj, Doldi, Philipp, Tyczynski, Bartosz, Kribben, Andreas, Flüh, Charlotte, Theilig, Franziska, Kunzendorf, Ulrich, Meier, Pascal, Krautwald, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712602/ https://www.ncbi.nlm.nih.gov/pubmed/33273695 http://dx.doi.org/10.1038/s41418-020-00690-y |
Ejemplares similares
-
Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice
por: von Samson-Himmelstjerna, Friedrich Alexander, et al.
Publicado: (2022) -
Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation
por: Moerke, Caroline, et al.
Publicado: (2019) -
Plasma Membrane Pores Drive Inflammatory Cell Death
por: Kolbrink, Benedikt, et al.
Publicado: (2020) -
Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury
por: Kolbrink, Benedikt, et al.
Publicado: (2022) -
TAT–RHIM: a more complex issue than expected
por: Kolbrink, Benedikt, et al.
Publicado: (2022)